NFKB1 and aneurysm: Indeed, these findings are consistent with the previous findings reported by us [51,52,53,54] and other researchers [55], showing that complement pathways and NF-κB activation contribute to atherogenesis and aneurysm, and inhibition of these pathways has a beneficial effect in treating atherogenesis.